Xuesaitong exerts long-term neuroprotection for stroke recovery by inhibiting the ROCKII pathway, in vitro and in vivo

J Ethnopharmacol. 2021 May 23:272:113943. doi: 10.1016/j.jep.2021.113943. Epub 2021 Feb 20.

Abstract

Ethnopharmacological relevance: Xuesaitong (XST) is a traditional Chinese medicine injection with neuroprotective properties and has been extensively used to treat stroke for many years. The main component of XST is Panax notoginseng saponins (PNS), which is the main extract of the Chinese herbal medicine Panax notoginseng.

Aim of the study: In this study, we investigated whether XST provided long-term neuroprotection by inhibiting neurite outgrowth inhibitor-A (Nogo-A) and the ROCKII pathway in experimental rats after middle cerebral artery occlusion (MCAO) and in SH-SY5Y cells exposed to oxygen-glucose deprivation/reperfusion (OGD/R).

Materials and methods: Rats with permanent MCAO were administered XST, Y27632, XST plus Y27632, and nimodipine for 14 and 28 days. Successful MCAO onset was confirmed by 2,3,5-triphenyl tetrazolium chloride (TTC) staining. Neurological deficit score (NDS) was used to assess neurological impairment. Hematoxylin-eosin (HE) staining and immunohistochemical (IHC) analysis of synaptophysin (SYN) and postsynaptic density protein-95 (PSD-95) were performed to evaluate cerebral ischemic injury and the neuroprotective capability of XST. Nogo-A levels and the ROCKII pathway were detected by IHC analysis, western blotting, and quantitative real-time polymerase chain reaction (qRT-PCR) to explore the protective mechanism of XST. OGD/R model was established in SH-SY5Y cells. Cell counting kit 8 (CCK8) was applied to detect the optimum OGD time and XST concentration. The expression levels Nogo-A and ROCKII pathway were determined using western blotting.

Results: Our results showed that XST reduced neurological dysfunction and pathological damage, promoted weight gain and synaptic regeneration, reduced Nogo-A mRNA and protein levels, and inhibited the ROCKII pathway in MCAO rats. CCK8 assay displayed that the optimal OGD time and optimal XST concentration were 7 h and 20 μg/mL respectively in SH-SY5Y cells. XST could evidently inhibit OGD/R-induced Nogo-A protein expression and ROCKII pathway activation in SH-SY5Y cells.

Conclusions: The present study suggested that XST exerted long-term neuroprotective effects that assisted in stroke recovery, possibly through inhibition of the ROCKII pathway.

Keywords: Nogo-A; Panax notoginseng saponins; ROCKⅡ; Stroke; Xuesaitong; Y27632.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Disease Models, Animal
  • Disks Large Homolog 4 Protein / metabolism
  • Drugs, Chinese Herbal / pharmacology*
  • Drugs, Chinese Herbal / therapeutic use
  • Humans
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Infarction, Middle Cerebral Artery / metabolism
  • Infarction, Middle Cerebral Artery / pathology
  • Male
  • Neuroprotection / drug effects
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Nogo Proteins / antagonists & inhibitors
  • Nogo Proteins / genetics
  • Nogo Proteins / metabolism
  • Panax notoginseng / chemistry
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / drug therapy
  • Saponins / pharmacology*
  • Saponins / therapeutic use
  • Signal Transduction / drug effects
  • Stroke / drug therapy
  • Synaptophysin / metabolism
  • Time Factors
  • rho GTP-Binding Proteins / genetics
  • rho GTP-Binding Proteins / metabolism
  • rho-Associated Kinases / antagonists & inhibitors*

Substances

  • Disks Large Homolog 4 Protein
  • Dlg4 protein, rat
  • Drugs, Chinese Herbal
  • Neuroprotective Agents
  • Nogo Proteins
  • Saponins
  • Synaptophysin
  • xuesetong
  • ROCK2 protein, human
  • ROCK2 protein, rat
  • rho-Associated Kinases
  • RhoA protein, rat
  • rho GTP-Binding Proteins